Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Wednesday, September 27, 2017

Public edition | newswise.com

News from the American Society for Radiation Oncology’s (ASTRO’s) 59th Annual Meeting
 

American Society for Radiation Oncology’s (ASTRO’s) 59th Annual Meeting

September 24 – 27, 2017
San Diego Convention Center
More information here



Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment

A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Immune Response Prognostic for Prostate Cancer Survival, Recurrence and Response to Radiation Therapy

A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes. The analysis of more than 9,000 prostate tumors...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Uninsured Cancer Patients Saw Increased Coverage for Care Following Medicaid Expansion

A new study finds that Medicaid expansion enacted as part of the Patient Protection and Affordable Care Act (ACA) improved coverage for care for cancer patients receiving radiation therapy and potentially decreased health care disparities.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 26-Sep-2017 at 10:45 ET


Aggressively Reduced Radiation Therapy for HPV-Related Throat Cancer Achieves Similar Control Rates with Fewer Side Effects

For certain patients with oropharyngeal cancer caused by the human papilloma virus (HPV), an aggressive reduction of radiation therapy after surgery may provide excellent cancer control while simultaneously reducing post-treatment side effects, impro...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 25-Sep-2017 at 14:00 ET


Phase III Trial Confirms Pelvic Radiation as Standard of Care for High-Risk, Early-Stage Endometrial Cancer

In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plu...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 25-Sep-2017 at 14:00 ET


Breast Cancer Patients Largely Find Radiation Therapy Experience Better Than Expected

A new survey finds breast cancer patients’ actual radiation therapy experiences largely exceeded their expectations.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 25-Sep-2017 at 10:45 ET


Accelerated Breast Radiation Therapy Following Mastectomy Shortens Treatment Time While Maintaining Tumor Control

Radiation therapy following mastectomy for intermediate-stage, high-risk breast cancer can be shortened from five to three weeks while maintaining tumor control rates in the breast and surrounding region that are equivalent to conventional treatment,...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Adding Radiation to Chemotherapy May Dramatically Improve Survival for Advanced-Stage NSCLC Patients

Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomiz...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 24-Sep-2017 at 16:00 ET


Distress Associated with Missed Appointments and Hospital Admission During Cancer Treatment

Psychological distress has long been associated with negative health outcomes for cancer patients, though specific reasons remain unclear.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 24-Sep-2017 at 16:15 ET


Long-Term Survival Rates More Than Double Previous Estimates for Locally Advanced Lung Cancer

Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous estimates.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 24-Sep-2017 at 16:00 ET


Study at Urban Cancer Center Finds 75 Percent of Its Depressed Patients Were Previously Undiagnosed

A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care—undiagnosed depression.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 24-Sep-2017 at 16:15 ET


Radiation-Immunotherapy Combination Can Slow Tumor Growth for Some Patients with Metastatic Late-Stage Cancer

A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the cancer.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Embargo expired on 24-Sep-2017 at 16:00 ET


International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer

Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fr...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application